DekaBank Deutsche Girozentrale’s Repare Therapeutics RPTX Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio RPTX Stock Details RPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-40,000	Closed	-$430K	–	1521
2023 Q2	$430K	Buy	40,000 +25,400	+174%	+$262K	﹤0.01%	1051
2023 Q1	$138K	Hold	14,600	–	–	﹤0.01%	1229
2022 Q4	$221K	Hold	14,600	–	–	﹤0.01%	1206
2022 Q3	$177K	Hold	14,600	–	–	﹤0.01%	1247
2022 Q2	$199K	Hold	14,600	–	–	﹤0.01%	1188
2022 Q1	$210K	Buy	14,600 +1,300	+10%	+$19.3K	﹤0.01%	1202
2021 Q4	$275K	Buy	13,300 +400	+3%	+$9.42K	﹤0.01%	1213
2021 Q3	$332K	Hold	12,900	–	–	﹤0.01%	1121
2021 Q2	$424K	Hold	12,900	–	–	﹤0.01%	1104
2021 Q1	$378K	Hold	12,900	–	–	﹤0.01%	1072
2020 Q4	$440K	Buy	+12,900	New	+$385K	﹤0.01%	1048

Other funds holding RPTX

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

DekaBank Deutsche Girozentrale's RPTX Position: Q3 2023 in Review

DekaBank Deutsche Girozentrale sold out of Repare Therapeutics (RPTX) in Q3 2023, closing a stake of 40,000 shares — an estimated $430K sold.

DekaBank Deutsche Girozentrale first reported a position in RPTX in Q4 2020 and held it in 11 quarters. The position peaked at $440K in Q4 2020. 76 funds tracked by Wall St. Rank hold RPTX as of Q3 2023.

DekaBank Deutsche Girozentrale reported no remaining Repare Therapeutics position as of Q3 2023 after selling out during the quarter.
DekaBank Deutsche Girozentrale sold 40,000 Repare Therapeutics shares in Q3 2023, an estimated $430K.
DekaBank Deutsche Girozentrale first reported a position in Repare Therapeutics in Q4 2020 and held it in 11 quarters.
DekaBank Deutsche Girozentrale's Repare Therapeutics position peaked at $440K in Q4 2020.
76 funds tracked by Wall St. Rank held Repare Therapeutics as of Q3 2023.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q3 2023, filed 13 Nov 2023.